Skip to main content

Month: November 2023

ARHT CAPSULE Showcases Hologram Content at Prime Video’s Candy Cane Lane Premiere Starring Eddie Murphy

TORONTO, Nov. 30, 2023 (GLOBE NEWSWIRE) — ARHT Media Inc. (“ARHT” or “the Company”) (TSXV:ART), (OTCQB:ARHTF) the global leader in the development, production, and distribution of high-quality, low latency hologram and digital content, today announces that Prime Video has once again utilized the ARHT CAPSULE hologram display to showcase content from the upcoming Eddie Murphy holiday movie Candy Cane Lane at The Culver City theatre in Los Angeles. The ARHT CAPSULE hologram display will contain Candy Cane Lane interactive content in the main lobby of the LA cinema. www.primevideo.com/explorecandycanelane   This is the third time Prime Video has used ARHT technology to promote their movies and television series including TwitchCon in Las Vegas to promote GEN V as an interactive campus tour and for BOYS Season...

Continue reading

VERB’s MARKET.live Welcomes Five More Retail Brands to Its Livestream Social Shopping Platform

LOS ALAMITOS, Calif. and LAS VEGAS, Nov. 30, 2023 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the “Company”), the company behind MARKET.live, the innovative multi-vendor, multi-presenter livestream social shopping platform, announces five dynamic new brands have joined the MARKET.live platform this week. The recent completion of the Company’s tech integrations with the ecommerce solutions powering thousands of vendors’ existing ecommerce stores are expected to continue to drive demand from retailers eager to create new and additional distribution channels and affiliate relationships through MARKET.live. Brands, retailers and creators that join MARKET.live have the ability to broadcast livestream shopping events simultaneously on numerous social media channels, including TikTok,...

Continue reading

Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIII

Investor Call with CEO, George Magrath, M.D., M.B.A., M.S. on December 5, 2023 FARMINGTON HILLS, Mich., Nov. 30, 2023 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refractive eye disorders, today announced that the Company’s CEO, George Magrath M.D., M.B.A., M.S., will deliver a presentation at the Ophthalmology Innovation Summit (OIS XIII), to take place in San Diego, CA on December 1-2, 2023. Dr. Magrath will also host a conference call for the investment community on Tuesday, December 5, 2023. During this call he will provide a strategic update, including the company’s plans to advance APX3330 into registrational trials in diabetic retinopathy in 2024.OIS...

Continue reading

Aeries Technology Reports Results for Second Fiscal Quarter and First Fiscal Half 2024

Revenues for the second fiscal quarter of 2024 were $17.6 million, up 38% year-over-year Adjusted EBITDA for the second fiscal quarter of 2024 was $2.9 million, up 107% year-over-year NEW YORK, Nov. 30, 2023 (GLOBE NEWSWIRE) — Aeries Technology (Nasdaq: AERT), a global professional services and consulting partner, today reported results of Aark Singapore Pte. Ltd. for the second fiscal quarter and first fiscal half 2024 ended September 30, 2023. On November 6, 2023, Aark Singapore Pte. Ltd., the parent company of Aeries Technology Group Business Accelerators Pte. Ltd., completed a business combination with Worldwide Webb Acquisition Corp., a publicly traded special purpose acquisition company. Following the business combination, Aark Singapore Pte. Ltd. became a subsidiary of the resulting public company, now known as Aeries Technology,...

Continue reading

BOS Reports Financial Results for the Third Quarter of the Year 2023

RISHON LE ZION, Israel, Nov. 30, 2023 (GLOBE NEWSWIRE) — BOS Better Online Solutions Ltd. (“BOS” or the “Company”) (NASDAQ: BOSC) reported its financial results for the third quarter of the year 2023. Third Quarter 2023 Statements of Operations Highlights:Revenues for the third quarter of 2023 grew by 8.5% to $9.8 million from $9.0 million in the comparable quarter last year. Operating profit for the third quarter of 2023 increased by 87.7% to $441,000 from $235,000 in the comparable quarter last year. EBITDA for the third quarter of 2023 increased by 70.4% to $600,000 from $352,000 in the comparable quarter last year. Financial expenses for the third quarter of 2023 increased to $128,000 from $3,000 in the comparable quarter last year due to currency exchange costs between the NIS and the US$.  Net income for...

Continue reading

Oil-Free Screw Compressor Market Size to Hit $3.57 Billion by 2030 | exhibiting a CAGR of 5.0%

The Oil-Free Screw Compressor Market to Hit USD 3.57 Billion by 2030; Technological Upgrades for Air System Control and Management to Augment Market Growth: Fortune Business Insights™ Pune, India, Nov. 30, 2023 (GLOBE NEWSWIRE) — The global oil-free screw compressor market size was valued at USD 2.43 billion in 2022 & market is projected to grow from USD 2.54 billion in 2023 to USD 3.57 billion by 2030, exhibiting a CAGR of 5.0% during the forecast period. Fortune Business Insights™ mentioned this in a report titled “Oil-Free Screw Compressor Market, 2023-2030.” Oil-free screw compressor is a screw compresses the air without any help from the oil seal. A screw compressor is made from raw materials, such as aluminum & steel, as well as other parts such as bearings, crankshafts, switches, gauges, rotors, and...

Continue reading

Update: Virtune AB (Publ) is launching Virtune Chainlink ETP on Nasdaq Stockholm 

Stockholm, November 30th, 2023 – Virtune, a Swedish regulated digital asset manager in Sweden is launching a new innovative crypto ETP on Nasdaq Stockholm, the largest stock exchange in the Nordic region. Today, Virtune is announcing the introduction of Virtune Chainlink ETP, providing exposure to Chainlink through a proven and well established financial instrument with a 100% physically backed structure. The ETP which is 100% physically backed and fully collateralized is denominated in SEK for the Swedish audience and is available on Avanza and Nordnet.   Chainlink is currently among the top 15 largest cryptocurrencies with a market capitalization of about USD 8,2 billion and has experienced a 165% growth during 2023 year to date. Chainlink acts like a bridge for smart contracts on different blockchains, making them all work together....

Continue reading

REE Automotive Announces Third Quarter 2023 Financial Results

Strong growing demand for P7, focused operational efficiencies, first demo vehicles planned to be shipped to customers in December TEL AVIV, Israel, Nov. 30, 2023 (GLOBE NEWSWIRE) — REE Automotive Ltd. (Nasdaq: REE), an automotive technology company and provider of full by-wire electric trucks and platforms, today announced its financial results for the third quarter ended September 30, 2023, through a shareholder letter posted on the company’s investor relations website HERE. The company will also hold a conference call today, November 30, 2023 at 8:30 a.m. ET. The live webcast of the conference call can be accessed on the Investors section of the Company’s website HERE. For the telephone conference online registration click HERE. Q3 23 Highlights:Expanded our dealer network, resulting in more than doubling initial order book...

Continue reading

Two Senior Healthcare Industry Professionals Join FTI Consulting’s Healthcare Business Transformation Practice

WASHINGTON, Nov. 30, 2023 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointments of Leisa Maddoux as a Senior Managing Director and Laura Marston as a Managing Director in the Healthcare Business Transformation practice within the firm’s Corporate Finance & Restructuring segment. “Leisa and Laura have strong reputations of helping healthcare clients through transformative changes,” said Brian Flynn, Co-Leader of the Healthcare Business Transformation practice. “Health systems today are facing pressures from many angles, whether it’s financial, regulatory or operational. I look forward to seeing the innovative solutions that Leisa and Laura will provide for our clients, allowing them to manage costs and systems without losing sight of quality patient care.” Ms. Maddoux, who is based in Denver,...

Continue reading

Lexicon Enrolls First Patient in Phase 2b Progress Study of LX9211 in Diabetic Peripheral Neuropathic Pain (DPNP)

The PROGRESS study marks initiation of the late-stage development program for AAK1 inhibitor LX9211, with potential to become the first new, non-opioid drug therapy in high-unmet need neuropathic pain in more than 20 years LX9211 has previously received Fast Track designation from the U.S. Food and Drug Administration (FDA) for DPNP THE WOODLANDS, Texas, Nov. 30, 2023 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that it has enrolled the first patient in PROGRESS (A Phase 2b, Dose-ranging, Randomized, Double-blind, PlacebO-controlled, Parallel-GRoup, MulticEnter Study with an Open-label Extension in PatientS with Diabetic Peripheral Neuropathic Pain) studying LX9211, a potent, orally-delivered, selective, investigational small molecule inhibitor of adaptor-associated kinase 1 (AAK1). PROGRESS will...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.